Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.
Lee K, Kim J, Hong S, Seong D, Choi Y, Ahn Y, Kim K, Kim S, Lee S, Sim W, Kim D, Jun B, Yang J, Yon D, Lee S, Kim M, Dragioti E, Li H, Jacob L, Koyanagi A, Abou Ghayda R, Shin J, Smith L. Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles. European Review For Medical And Pharmacological Sciences 2020, 24: 13089-13097. PMID: 33378062, DOI: 10.26355/eurrev_202012_24216.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAsian PeopleBlack PeopleCoronary Artery DiseaseCOVID-19COVID-19 Drug TreatmentDatabases, FactualDiabetes MellitusDrug Therapy, CombinationEnzyme InhibitorsHeart FailureHumansHydroxychloroquineHypertensionImmunocompromised HostInformation DisseminationMacrolidesObesityOrgan Dysfunction ScoresProtective FactorsPulmonary Disease, Chronic ObstructiveRandomized Controlled Trials as TopicRetraction of Publication as TopicRisk FactorsSARS-CoV-2Severity of Illness IndexSex FactorsSmokingConceptsAssociated with higher risk of mortalityAssociated with higher riskHigher risk of mortalityAngiotensin receptor blockersRisk of mortalityAngiotensin-converting enzyme inhibitorsAssociated with reduced riskAngiotensin-converting enzymeSystematic reviewRisk factorsCombination therapyCOVID-19 mortalityAssociated with reduced risk of mortalityCombination therapy of hydroxychloroquineSystematic review of randomized controlled trialsReview of randomized controlled trialsRelevant cohort studiesClinical risk factorsClinical issuesRandomized Controlled TrialsCOVID-19 patientsReceptor blockersCohort studyControlled TrialsCOVID-19
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply